| Literature DB >> 29477368 |
Chukwuka Eze1, Farkhad Manapov2, Christian Gratzke3, Nina-Sophie Schmidt-Hegemann2, Andreas Jung4, Thomas Kirchner4, Volker Heinemann5, Christian G Stief3, Claus Belka2, Stefan Boeck5.
Abstract
Entities:
Keywords: Adenosquamous-cell carcinoma; Immune checkpoint inhibitor; Nivolumab; Prostate cancer; Radiotherapy
Mesh:
Substances:
Year: 2018 PMID: 29477368 DOI: 10.1016/j.ejca.2018.01.086
Source DB: PubMed Journal: Eur J Cancer ISSN: 0959-8049 Impact factor: 9.162